Nishimura Y, Maiocco J, Janda G, Nedved A, Han Y, Durani U, Nowakowski GS, Paludo J, Thanarajasingam G, Micallef I, Johnston P, Witzig T, Habermann T, Maurer M, Armand P, Ansell SM, Abeykoon J. Clinical outcomes and safety of the immune checkpoint inhibitor rechallenge in Hodgkin lymphoma: an off-trial analysis. Haematologica; https://doi.org/10.3324/haematol.2026.301311 [Early view].